KwongYD, LiuKD, HsuC-Y, CooperB, PalevskyPM, KellumJA, et al.: Subgroups of patients with distinct health utility profiles after AKI. Kidney3604: 881–889, 2023PubMed
JohansenKL, SmithMW, UnruhML, SirokaAM, O’ConnorTZ, PalevskyPM, VA/NIH Acute Renal Failure Trial Network: Predictors of health utility among 60-day survivors of acute kidney injury in the Veterans Affairs/National Institutes of Health Acute Renal Failure Trial Network Study. Clin J Am Soc Nephrol5: 1366–1372, 2010PubMed
JohansenKL, SmithMW, UnruhML, SirokaAM, O’ConnorTZ, PalevskyPM, VA/NIH Acute Renal Failure Trial Network: Predictors of health utility among 60-day survivors of acute kidney injury in the Veterans Affairs/National Institutes of Health Acute Renal Failure Trial Network Study. Clin J Am Soc Nephrol 5: 1366–1372, 2010PubMed)| false
AhlstromA, TallgrenM, PeltonenS, RasanenP, PettilaV: Survival and quality of life of patients requiring acute renal replacement therapy. Intensive Care Med31: 1222–1228, 2005PubMed
AhlstromA, TallgrenM, PeltonenS, RasanenP, PettilaV: Survival and quality of life of patients requiring acute renal replacement therapy. Intensive Care Med 31: 1222–1228, 2005PubMed)| false
GaudryS, HajageD, SchortgenF, Martin-LefevreL, PonsB, BouletE, AKIKI Study Group, et al.: Initiation strategies for renal-replacement therapy in the intensive care unit. N Engl J Med375: 122–133, 2016PubMed
GaudryS, HajageD, SchortgenF, Martin-LefevreL, PonsB, BouletE, AKIKI Study Group, : Initiation strategies for renal-replacement therapy in the intensive care unit. N Engl J Med 375: 122–133, 2016PubMed)| false
BarbarSD, Clere-JehlR, BourredjemA, HernuR, MontiniF, BruyereR, IDEAL-ICU Trial Investigators and the CRICS TRIGGERSEP Network, et al.: Timing of renal-replacement therapy in patients with acute kidney injury and sepsis. N Engl J Med379: 1431–1442, 2018PubMed
BarbarSD, Clere-JehlR, BourredjemA, HernuR, MontiniF, BruyereR, IDEAL-ICU Trial Investigators and the CRICS TRIGGERSEP Network, : Timing of renal-replacement therapy in patients with acute kidney injury and sepsis. N Engl J Med 379: 1431–1442, 2018PubMed)| false
BagshawSM, WaldR, AdhikariNKJ, BellomoR, da CostaBR, DreyfussD, Canadian Critical Care Trials Group, Australian and New Zealand Intensive Care Society Clinical Trials Group, United Kingdom Critical Care Research Group, Canadian Nephrology Trials Network, et al.: Timing of initiation of renal-replacement therapy in acute kidney injury. N Engl J Med383: 240–251, 2020PubMed
BagshawSM, WaldR, AdhikariNKJ, BellomoR, da CostaBR, DreyfussD, Canadian Critical Care Trials Group, Australian and New Zealand Intensive Care Society Clinical Trials Group, United Kingdom Critical Care Research Group, Canadian Nephrology Trials Network, : Timing of initiation of renal-replacement therapy in acute kidney injury. N Engl J Med 383: 240–251, 2020PubMed)| false
GaudryS, HajageD, Martin-LefevreL, LebbahS, LouisG, MoschiettoS, et al.: Comparison of two delayed strategies for renal replacement therapy initiation for severe acute kidney injury (AKIKI 2): A multicentre, open-label, randomised, controlled trial. Lancet397: 1293–1300, 2021PubMed
RambaudT, HajageD, DreyfussD, LebbahS, Martin-LefevreL, LouisG, et al.: Renal replacement therapy initiation strategies in comatose patients with severe acute kidney injury: A secondary analysis of a multicenter randomized controlled trial. Intensive Care Med50: 385–394, 2024PubMed
RambaudT, HajageD, DreyfussD, LebbahS, Martin-LefevreL, LouisG, : Renal replacement therapy initiation strategies in comatose patients with severe acute kidney injury: A secondary analysis of a multicenter randomized controlled trial. Intensive Care Med 50: 385–394, 2024PubMed)| false
McCoyIE, WeinhandlE, HusseinW, HsuCY: Initial management and potential opportunities to deprescribe dialysis among patients with AKI–D patients after hospital discharge. J Am Soc Nephrol34: 1949–1951, 2023PubMed
McCoyIE, WeinhandlE, HusseinW, HsuCY: Initial management and potential opportunities to deprescribe dialysis among patients with AKI–D patients after hospital discharge. J Am Soc Nephrol 34: 1949–1951, 2023PubMed)| false
KatulkaRJ, Al SaadonA, SebastianskiM, FeatherstoneR, VandermeerB, SilverSA, et al.: Determining the optimal time for liberation from renal replacement therapy in critically ill patients: A systematic review and meta-analysis (DOnE RRT). Crit Care24: 50, 2020PubMed
KatulkaRJ, Al SaadonA, SebastianskiM, FeatherstoneR, VandermeerB, SilverSA, : Determining the optimal time for liberation from renal replacement therapy in critically ill patients: A systematic review and meta-analysis (DOnE RRT). Crit Care 24: 50, 2020PubMed)| false
WangY, GallagherM, LiQ, LoS, CassA, FinferS, et al.: Renal replacement therapy intensity for acute kidney injury and recovery to dialysis independence: A systematic review and individual patient data meta-analysis. Nephrol Dial Transplant33: 1017–1024, 2018PubMed
BouchardJ, SorokoSB, ChertowGM, HimmelfarbJ, IkizlerTA, PaganiniEP, Program to Improve Care in Acute Renal Disease (PICARD) Study Group, et al.: Fluid accumulation, survival and recovery of kidney function in critically ill patients with acute kidney injury. Kidney Int76: 422–427, 2009PubMed
BouchardJ, SorokoSB, ChertowGM, HimmelfarbJ, IkizlerTA, PaganiniEP, Program to Improve Care in Acute Renal Disease (PICARD) Study Group, : Fluid accumulation, survival and recovery of kidney function in critically ill patients with acute kidney injury. Kidney Int 76: 422–427, 2009PubMed)| false
BellomoR, CassA, ColeL, FinferS, GallagherM, LeeJ, RENAL Replacement Therapy Study Investigators, et al.: An observational study fluid balance and patient outcomes in the Randomized Evaluation of Normal vs. Augmented Level of Replacement Therapy trial. Crit Care Med40: 1753–1760, 2012PubMed
BellomoR, CassA, ColeL, FinferS, GallagherM, LeeJ, RENAL Replacement Therapy Study Investigators, : An observational study fluid balance and patient outcomes in the Randomized Evaluation of Normal vs. Augmented Level of Replacement Therapy trial. Crit Care Med 40: 1753–1760, 2012PubMed)| false
MuruganR, KertiSJ, ChangCH, GallagherM, ClermontG, PalevskyPM, et al.: Association of et ultrafiltration rate with mortality among critically ill adults with acute kidney injury receiving continuous venovenous hemodiafiltration: A secondary analysis of the Randomized Evaluation of Normal vs Augmented Level (RENAL) of Renal Replacement Therapy trial. JAMA Netw Open2: e195418, 2019PubMed
MuruganR, KertiSJ, ChangCH, GallagherM, ClermontG, PalevskyPM, : Association of et ultrafiltration rate with mortality among critically ill adults with acute kidney injury receiving continuous venovenous hemodiafiltration: A secondary analysis of the Randomized Evaluation of Normal vs Augmented Level (RENAL) of Renal Replacement Therapy trial. JAMA Netw Open 2: e195418, 2019PubMed)| false
Beaubien-SoulignyW, TrottT, NeyraJA: How to determine fluid management goals during continuous kidney replacement therapy in patients with AKI: Focus on POCUS. Kidney3603: 1795–1806, 2022PubMed
Beaubien-SoulignyW, TrottT, NeyraJA: How to determine fluid management goals during continuous kidney replacement therapy in patients with AKI: Focus on POCUS. Kidney360 3: 1795–1806, 2022PubMed)| false
MuruganR, ChangCH, RazaM, NikravangolsefidN, HuangDT, PalevskyPM, (RELIEVE-AKI) Study Investigators, et al.: Restrictive versus Liberal Rate of Extracorporeal Volume Removal Evaluation in Acute Kidney Injury (RELIEVE-AKI): A pilot clinical trial protocol. BMJ Open13: e075960, 2023PubMed
MuruganR, ChangCH, RazaM, NikravangolsefidN, HuangDT, PalevskyPM, (RELIEVE-AKI) Study Investigators, : Restrictive versus Liberal Rate of Extracorporeal Volume Removal Evaluation in Acute Kidney Injury (RELIEVE-AKI): A pilot clinical trial protocol. BMJ Open 13: e075960, 2023PubMed)| false
DouvrisA, ZeidK, HiremathS, BagshawSM, WaldR, Beaubien-SoulignyW, et al.: Mechanisms for hemodynamic instability related to renal replacement therapy: A narrative review. Intensive Care Med45: 1333–1346, 2019PubMed
DouvrisA, ZeidK, HiremathS, BagshawSM, WaldR, Beaubien-SoulignyW, : Mechanisms for hemodynamic instability related to renal replacement therapy: A narrative review. Intensive Care Med 45: 1333–1346, 2019PubMed)| false
WaldR, GaudryS, da CostaBR, AdhikariNKJ, BellomoR, DuB, STARRT-AKI Investigators, et al.: Initiation of continuous renal replacement therapy versus intermittent hemodialysis in critically ill patients with severe acute kidney injury: A secondary analysis of STARRT-AKI trial. Intensive Care Med49: 1305–1316, 2023PubMed
WaldR, GaudryS, da CostaBR, AdhikariNKJ, BellomoR, DuB, STARRT-AKI Investigators, : Initiation of continuous renal replacement therapy versus intermittent hemodialysis in critically ill patients with severe acute kidney injury: A secondary analysis of STARRT-AKI trial. Intensive Care Med 49: 1305–1316, 2023PubMed)| false
HryciwN, JoannidisM, HiremathS, CallumJ, ClarkEG: Intravenous Albumin for Mitigating Hypotension and Augmenting Ultrafiltration during Kidney Replacement Therapy. Clin J Am Soc Nephrol16: 820–828, 2021PubMed
MacedoE, KarlB, LeeE, MehtaRL: A randomized trial of albumin infusion to prevent intradialytic hypotension in hospitalized hypoalbuminemic patients. Crit Care25: 18, 2021PubMed
MacedoE, KarlB, LeeE, MehtaRL: A randomized trial of albumin infusion to prevent intradialytic hypotension in hospitalized hypoalbuminemic patients. Crit Care 25: 18, 2021PubMed)| false
ClarkEG, McIntyreL, WatpoolI, KongJWY, RamsayT, SabriE, et al.: Intravenous albumin for the prevention of hemodynamic instability during sustained low-efficiency dialysis: a randomized controlled feasibility trial (The SAFER-SLED Study). Ann Intensive Care11: 174, 2021PubMed
ClarkEG, McIntyreL, WatpoolI, KongJWY, RamsayT, SabriE, : Intravenous albumin for the prevention of hemodynamic instability during sustained low-efficiency dialysis: a randomized controlled feasibility trial (The SAFER-SLED Study). Ann Intensive Care 11: 174, 2021PubMed)| false